Skip to main content
Log in

Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Objective

The pharmacological profile of escitalopram, the S-(+)-enantiomer of citalopram, was studied and compared with citalopram and the R-(−)-enantiomer, R-citalopram.

Methods

Inhibition of the serotonin transporter (5-HTT) was studied in COS-1 cells expressing the human 5-HTT (h-5-HTT) and in rat brain synaptosomes. In vitro selectivity was studied relative to noradrenaline transporter (NAT) and dopamine transporter (DAT) function in rat brain synaptosomes, and affinities for other binding sites were determined. In vivo 5-HT activity was measured as inhibition of neuronal firing rate in rat dorsal raphe nucleus (DRN) and enhancement of 5-hydroxytryptophan (5-HTP)-induced behaviour (mouse and rat). Furthermore, studies were conducted in models of antidepressant (mouse forced-swim test), anxiolytic [foot-shock-induced ultrasonic vocalization (USV) in adult rats and mouse black and white box] and anti-aggressive activity (socially isolated mice).

Results

Escitalopram inhibited 5-HTT functions approximately 2 times more potently than citalopram and at least 40 times more potently than R-citalopram. Escitalopram showed insignificant activity at other monoamine transporters and 144 other binding sites. Escitalopram inhibited 5-HT neuronal firing in DRN and potentiated 5-HTP-induced behaviours more potently than citalopram; R-citalopram was inactive. Escitalopram and citalopram, but not R-citalopram, reduced forced-swimming-induced immobility and facilitated exploratory behaviour in the black and white box. Escitalopram and citalopram inhibited USV potently; R-citalopram was several times less potent. Escitalopram, citalopram and R-citalopram inhibited aggressive behaviour weakly. Escitalopram and citalopram had very potent anti-aggressive effects when co-administered with l-5-HTP.

Conclusion

Escitalopram is a very selective 5-HT reuptake inhibitor. It is more potent than its racemate citalopram and is effective in animal models predictive of antidepressant and anxiolytic activities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2A–C.
Fig. 3.
Fig. 4.
Fig. 5A, B.

Similar content being viewed by others

References

  • Aghajanian GK (1978) Feedback regulation of central monaminergic neurones: evidence from single-cell recording studies. In: Youdim MBH, Lovenberg W, Sharman DF, Lagando JR (eds) Essays in neurochemistry and neuropharmacology. Wiley, New York, pp 1–32

  • Blier P, de Montigny C (1997) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220–226

    Google Scholar 

  • Borsini F (1995) Role of the serotonergic system in the forced swimming test. Neurosci Biobehav Rev 19:377–395

    CAS  PubMed  Google Scholar 

  • Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94:147–160

    CAS  PubMed  Google Scholar 

  • Burke WJ, Gergel I, Bose A (2002) Fixed-dose trial of the single isomer SSRI escitalopram in depressed out patients. J Clin Psychiatry 63:331–336

    CAS  PubMed  Google Scholar 

  • Caldwell J (2002) Do single enantiomers have something special to offer? Hum Psychopharmacol Clin Exp 16:S67–S71

    Article  Google Scholar 

  • Costall B, Jones BJ, Kelly ME, Naylor RJ, Tomkins DM (1989) Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32:777–785

    CAS  PubMed  Google Scholar 

  • Crawley J, Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:167–170

    CAS  Google Scholar 

  • De Vry J, Benz U, Schreiber R, Traber J (1993) Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anxiolytic drugs. Eur J Pharmacol 249:331–339

    PubMed  Google Scholar 

  • Gardner CR (1985) Distress vocalization in rat pups. A simple screening method for anxiolytic drugs. J Pharmacol Methods 14:181–187

    Google Scholar 

  • Gorman JM, Korotzer A, Su G (2002) Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo controlled trials. CNS Spectrums 7:40–44

    Google Scholar 

  • Hall H, Ögren SO (1984) Effects of antidepressant drugs on histamine-H1 receptors in the brain. Life Sci 34:597–605

    Article  CAS  PubMed  Google Scholar 

  • Hyttel J (1982) Citalopram. Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Progr Neuropsychopharmacol Biol Psychiatry 6:177–295

    Google Scholar 

  • Hyttel J, Bøgesø KP, Perregaard J, Sánchez C (1992) The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer. J Neur Transm 88:157–160

    CAS  Google Scholar 

  • Kaltwasser MT (1990) Startle-inducing acoustic stimuli evoke ultrasonic vocalization in the rat. Physiol Behav 48:13–17

    CAS  PubMed  Google Scholar 

  • Meier E, Frederiksen K, Nielsen M, Lembøl HL, Pedersen H, Hyttel J (1997) Pharmacological in vitro characterization of Lu 25–109-T, a muscarinic compound with M1-agonistic and M2/M3-antagonistic properties. Drug Dev Res 40:1–16

    Article  CAS  Google Scholar 

  • Montgomery SA, Loft H, Sánchez C, Reines EH, Papp M (2001) Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model. Pharmacol Toxicol 88:282–286

    CAS  PubMed  Google Scholar 

  • Olivier B, van Oorschot R, Mos J (1998) Rodent models of aggressive behaviour. In: Maes M, Coccaro E (eds) Neurobiology of aggression and impulsivity. Wiley, London, pp 167–182

  • Owens MJ, Rosenbaum JF (2002) Escitalopram: a second generation SSRI. CNS Spectr 7:34–39

    Google Scholar 

  • Owens MJ, Knight DL, Nemeroff CB (2001) Second-generation SSRIs: Human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 50:345–350

    Article  CAS  PubMed  Google Scholar 

  • Porsolt RD, Bertin A, Jalfre M (1977) Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336

    CAS  PubMed  Google Scholar 

  • Romero L, Bel N, Artigas F, de Montigny C, Blier P (1996) Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 15:349–360

    Article  CAS  PubMed  Google Scholar 

  • Sánchez C (1993) Effect of serotonergic drugs on footshock-induced ultrasonic vocalization in adult male rats. Behav Pharmacol 4:269–277

    PubMed  Google Scholar 

  • Sánchez C (1995) Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white test box. Pharmacol Toxicol 77:71–78

    CAS  PubMed  Google Scholar 

  • Sánchez C (1998) 5-HT1A receptors in the treatment of aggression and impulse control disorders (ICDs). In: Maes M, Coccaro E (eds) Neurobiology of aggression and impulsivity. Wiley, London, pp 181–196

  • Sánchez C (2003) Stress-induced vocalisation in adult animals. A valid model of anxiety? Eur J Pharmacol (in press)

  • Sánchez C, Hyttel J (1994) Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors. Eur J Pharmacol 264:241–247

    CAS  PubMed  Google Scholar 

  • Sánchez C, Meier E (1997) Behavioral profile of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology 129:197–205

    CAS  PubMed  Google Scholar 

  • Sánchez C, Arnt J, Hyttel J, Moltzen EK (1993) The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice. Psychopharmacology 110:53–59

    CAS  PubMed  Google Scholar 

  • Sánchez C, Arnt J, Costall B, Kelly ME, Meier E, Naylor RJ, Perregaard J (1997) The selective σ2 ligand Lu 28–179 has potent anxiolytic-like effects in rodents. J Pharmacol Exp Ther 283:1343–1353

    Google Scholar 

  • Schreiber R, Melon C, De Vry J (1998) The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalisation test. Psychopharmacology 135:383–391

    CAS  PubMed  Google Scholar 

  • Tonoue T, Ashida Y, Makino H, Hata H (1986) Inhibition of shock-elicited ultrasonic vocalization by opioid peptides in the rat: a psychotropic effect. Psychoneuroendocrinology 11:177–184

    CAS  PubMed  Google Scholar 

  • Wade A, Lemming OM, Hedegaard KB (2002) Escitalopram 10 mg/day is effective and well tolerated in a placebo controlled study in depression in primary care. Int Clin Psychopharmacol 17:95–102

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The excellent technical assistance of Betina Dobel Frederiksen, Jeanne Jakobsen, Søren Hansen, Bente Ladegaard, Karin Larsen and Dorit Skov is highly appreciated.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Sánchez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sánchez, C., Bergqvist, P.B.F., Brennum, L.T. et al. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology 167, 353–362 (2003). https://doi.org/10.1007/s00213-002-1364-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-002-1364-z

Keywords

Navigation